[Current practice and future prospects of AIDS-therapy].
Oka
S
S
Department of Infectious Diseases, University of Tokyo.
Goto
H
H
Kimura
S
S
Shimada
K
K
D000163:Acquired Immunodeficiency Syndrome / Q000378:metabolism / Q000628:therapy*; D001569:Benzodiazepines / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007093:Imidazoles / Q000493:pharmacokinetics / Q000627:therapeutic use*; D007372:Interferons / Q000008:administration & dosage*; D013871:Thiones / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use; D016047:Zalcitabine / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D015215:Zidovudine / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics
D007093:Imidazoles; D013871:Thiones; D014409:Tumor Necrosis Factor-alpha; D001569:Benzodiazepines; D015215:Zidovudine; D016047:Zalcitabine; D007372:Interferons